Cargando…
Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema
Atopic eczema, also known as atopic dermatitis, is a frequent, highly pruritic, chronic skin disease, which is typically running in flares. The traditional treatment mainly consists of the reactive application of topical anti-inflammatory agents such as topical corticosteroids and topical calcineuri...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412232/ https://www.ncbi.nlm.nih.gov/pubmed/22879707 http://dx.doi.org/10.5021/ad.2012.24.3.253 |
_version_ | 1782239940676943872 |
---|---|
author | Wollenberg, Andreas Ehmann, Laura Maximiliane |
author_facet | Wollenberg, Andreas Ehmann, Laura Maximiliane |
author_sort | Wollenberg, Andreas |
collection | PubMed |
description | Atopic eczema, also known as atopic dermatitis, is a frequent, highly pruritic, chronic skin disease, which is typically running in flares. The traditional treatment mainly consists of the reactive application of topical anti-inflammatory agents such as topical corticosteroids and topical calcineurin inhibitors. The short term benefit of this approach is well known, but long term remission between flares is difficult to achieve. Therefore, innovative long-term treatment strategies targeting flare prevention and skin barrier stabilization are needed. We and others have shown that normal looking, non-lesional skin of atopic dermatitis patients is immunobiologially not normal but characterized by an invisible inflammation and barrier defect. This has led to the novel concept of proactive therapy, which is defined as long-term, low-dose intermittent application of anti-inflammatory therapy to the previously affected skin, together with an ongoing emollient treatment of unaffected skin. This review article describes the most important long-term treatment options for atopic dermatitis, which includes emollient therapy, the novel concept of proactive treatment, the different ultraviolet light modalities and a selection of systemic immunosuppressive drugs and biologics. Current trial data, licensed indications, off-label use and relevant side effects of the different treatment modalities are summarized. |
format | Online Article Text |
id | pubmed-3412232 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Korean Dermatological Association; The Korean Society for Investigative Dermatology |
record_format | MEDLINE/PubMed |
spelling | pubmed-34122322012-08-09 Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema Wollenberg, Andreas Ehmann, Laura Maximiliane Ann Dermatol Review Article Atopic eczema, also known as atopic dermatitis, is a frequent, highly pruritic, chronic skin disease, which is typically running in flares. The traditional treatment mainly consists of the reactive application of topical anti-inflammatory agents such as topical corticosteroids and topical calcineurin inhibitors. The short term benefit of this approach is well known, but long term remission between flares is difficult to achieve. Therefore, innovative long-term treatment strategies targeting flare prevention and skin barrier stabilization are needed. We and others have shown that normal looking, non-lesional skin of atopic dermatitis patients is immunobiologially not normal but characterized by an invisible inflammation and barrier defect. This has led to the novel concept of proactive therapy, which is defined as long-term, low-dose intermittent application of anti-inflammatory therapy to the previously affected skin, together with an ongoing emollient treatment of unaffected skin. This review article describes the most important long-term treatment options for atopic dermatitis, which includes emollient therapy, the novel concept of proactive treatment, the different ultraviolet light modalities and a selection of systemic immunosuppressive drugs and biologics. Current trial data, licensed indications, off-label use and relevant side effects of the different treatment modalities are summarized. Korean Dermatological Association; The Korean Society for Investigative Dermatology 2012-08 2012-07-25 /pmc/articles/PMC3412232/ /pubmed/22879707 http://dx.doi.org/10.5021/ad.2012.24.3.253 Text en Copyright © 2012 The Korean Dermatological Association and The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Wollenberg, Andreas Ehmann, Laura Maximiliane Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema |
title | Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema |
title_full | Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema |
title_fullStr | Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema |
title_full_unstemmed | Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema |
title_short | Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema |
title_sort | long term treatment concepts and proactive therapy for atopic eczema |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412232/ https://www.ncbi.nlm.nih.gov/pubmed/22879707 http://dx.doi.org/10.5021/ad.2012.24.3.253 |
work_keys_str_mv | AT wollenbergandreas longtermtreatmentconceptsandproactivetherapyforatopiceczema AT ehmannlauramaximiliane longtermtreatmentconceptsandproactivetherapyforatopiceczema |